Cellumed and ARTES Sign Development and License Agreement
Cellumed Co. Ltd., listed stock market company and Germany based ARTES Biotechnology GmbH announce the execution of a Development and License Agreement aiming at...
BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of the BD SCF™ PremiumCoat®† Plunger Stopper in partnership with...
Merck and Ridgeback Announce Submission of EUA Application to the U.S. FDA for Molnupiravir for the Treatment of COVID-19 in At Risk Adults
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that Merck has submitted an Emergency Use Authorization (EUA) application...
NanoImaging Services Collaborates with Viva Biotech to Offer an Integrated CryoEM Gene-to-Structure Workflow to Streamline Target Discovery
NanoImaging Services, Inc., the premier industry provider of cryoEM services, microscope access and training, and Viva Biotech Holdings, a leading open-access and innovation-driven technology...
Enzolytics and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies
Samsung Biologics , a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to...
Navigo Proteins GmbH Announces Extension of Partnership with ITM for Targeted Radio Conjugates
Navigo Proteins, a premier protein engineering company developing optimized scaffold protein-based affinity ligands from its Precision Targeting toolbox announces the extension of their ongoing...
Biotium Debuts Novel Fluorescent Dyes that Push Emission Further into the Infrared Spectrum
Biotium, a leading supplier and inventor of fluorescent probes for life science research, announces the release of infrared CF®850 and CF®870 dyes. These novel...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...